Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors

Genes and Nutrition

Volumn 7, Issue 4, 2012, Pages 549-558

  Hakkak, Reza ^a,b   Al Dwairi, Ahmed ^b   Fuchs, George J ^b   Korourian, Soheila ^b   Simmen, Frank A ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Fatty acid synthase; Insulin; Malic enzyme 1; NAFLD; Rats; Soy; Steatosis

Indexed keywords

CASEIN; DIMETHYLBENZ[A]ANTHRACENE; FATTY ACID SYNTHASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; IODOTHYRONINE DEIODINASE 1; ISOFLAVONE; LIVER ENZYME; MALATE DEHYDROGENASE (DECARBOXYLATING); PHOSPHOGLUCONATE DEHYDROGENASE; SOYBEAN PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA 1; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL INFILTRATION; CHOLESTEROL METABOLISM RELATED GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY ACID SYNTHASE GENE; FATTY LIVER; FEMALE; GENE; GENE EXPRESSION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE GENE; HEPATIC LIPOGENIC ENZYME GENE; IODOTHYRONINE DEIODINASE 1 GENE; LEAN BODY WEIGHT; MALATE DEHYDROGENASE (DECARBOXYLATING) GENE; MONONUCLEAR CELL; NONHUMAN; OBESITY; PHOSPHOGLUCONATE DEHYDROGENASE GENE; PROTEIN EXPRESSION; PROTEIN INTAKE; RAT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C GENE; STEROL REGULATORY ELEMENT BINDING PROTEIN 2 GENE; THYROID HORMONE RECEPTOR ALPHA 1 GENE; THYROID HORMONE RECEPTOR BETA 1 GENE; THYROID HORMONE SYSTEM GENE; ZUCKER RAT;

RATTUS;

EID: 84872187088     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-012-0294-6     Document Type: Article

References (39)

1. Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282
2. Angulo P (2002) Treatment of nonalcoholic fatty liver disease. Ann Hepatol 1:12-19
3. Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R, Tovar AR (2004) Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134:522-529 (Pubitemid 38298490)
4. Bilici A, Ozguroglu M, Mihmanli I, Turna H, Adaletli I (2007) A case-control study of non-alcoholic fatty liver disease in breast cancer. Med Oncol 24:367-371 (Pubitemid 350135927)
5. Bray GA, York DA, Fisler JS (1989) Experimental obesity: A homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam Horm 45:1-125
6. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 40:1387-1395 (Pubitemid 39657013)
7. Buque X, Martinez MJ, Cano A, Miquilena-Colina ME, Garcia-Monzon C, Aspichueta P, Ochoa B (2010) A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. J Lipid Res 51:500-513
8. Chu CH, Lin SC, Shih SC, Kao CR, Chou SY (2003) Fatty metamorphosis of the liver in patients with breast cancer: Possible associated factors. World J Gastroenterol 9:1618-1620
9. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL (1996) Phenotypes of mouse diabetes and rat fatty liver due to mutations in the OB (leptin) receptor. Science 271:994-996 (Pubitemid 26066874)
10. Day CP (2005) Natural history of NAFLD: Remarkably benign in the absence of cirrhosis. Gastroenterology 129:375-378 (Pubitemid 41002070)
11. Gudbrandsen OA, Wergedahl H, Liaset B, Espe M, Berge RK (2005) Dietary proteins with high isoflavone content or low methionineglycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa/fa rats. Br J Nutr 94:321-330 (Pubitemid 41404274)
12. Gudbrandsen OA, Wergedahl H, Mork S, Liaset B, Espe M, Berge RK (2006) Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats. Br J Nutr 96:249-257 (Pubitemid 46470092)
13. Gudbrandsen OA, Wergedahl H, Berge K (2009) A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats. Nutrition 25:574-580
14. Hakkak R, Korourian S, Shelnutt SR, Lensing S, Ronis MJ, Badger TM (2000) Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats. Cancer Epidemiol Biomarkers Prev 9:113-117 (Pubitemid 30062917)
15. Hakkak R, Shaaf S, Jo C, MacLeod S, Korourian S (2011) Effects of high-isoflavone soy diet vs. casein protein diet and obesity on DMBA-induced mammary tumor development. Oncology Lett 2:29-36
16. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD (2002) Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am J Med 113(Supp 9B):71S-88S (Pubitemid 36151834)
17. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N (2003) Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133:1238-1243 (Pubitemid 36548688)
18. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesityrelated health risk factors, 2001. JAMA 289:76-79 (Pubitemid 36026281)
19. Nguyen MC, Stewart RB, Banerji MA, Gordon DH, Kral JG (2001) Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer. Int J Obes Relat Metab Disord 25:296-298
20. Ong JP, Younossi ZM (2007) Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 11:1-16 (Pubitemid 46829973)
21. Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE (2003) Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 77:171-183
22. Roberts EA (2007) Pediatric nonalcoholic fatty liver disease (NAFLD): A "growing" problem? J Hepatol 46:1133-1142 (Pubitemid 46680362)
23. Simmen RCM, Eason RR, Till SR, Chatman L Jr, Velarde MC, Geng Y, Korourian S, Badger TM (2005) Inhibition of NMU-induced mammary tumorigenesis by dietary soy. Cancer Lett 224:45-52 (Pubitemid 40720366)
24. Simmen FA, Mercado CP, Zavacki AM, Huang SA, Greenway AD, Kang P, Bowman MT, Prior RL (2010) Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat. J Nutr Biochem 21:1106-1113
25. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, Becker GW, Bowsher RR, Stephens TW, Caro JF (1996) Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 98:1277-1282 (Pubitemid 26322051)
26. Spydevold SO, Greenbaum AL, Baquer NZ, McLean P (1978) Adaptive responses of enzymes of carbohydrate and lipid metabolism to dietary alteration in genetically obese Zucker rats (fa/fa). Eur J Biochem 89:329-339 (Pubitemid 8405794)
27. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J et al (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271 (Pubitemid 26007816)
28. Torre-Villalvazo I, Tovar AR, Ramos-Barragan VE, Cerbon-Cervantes MA, Torres N (2008) Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 138:462-468 (Pubitemid 351355241)
29. Tovar AR, Murguia F, Cruz C, Hernandez-Pando R, Aguilar-Salinas CA, Pedraza-Chaverri J, Correa-Rotter R, Torres N (2002) A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 132:2562-2569 (Pubitemid 35013234)
30. Tovar AR, Torre-Villavazo I, Ochoa M et al (2005) Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res 46:1823-1832 (Pubitemid 41248478)
31. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
32. Wergedahl H, Liaset B, Gudbrandsen OA, Lied E, Espe M, Muna Z, Mork S, Berge RK (2004) Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134:1320-1327 (Pubitemid 38720701)
33. National Center for Health Statistics. http://www.cdc.gov/nchs/ nhanes.htm. National Health and Nutrition Examination Survey
34. WHO. http://www.who.int/nut/obs.htm. World Health Organization
35. Yang X, Deignan JL, Qi H, Zhu J, Qian S, Zhong J, Torosyan G, Majid S, Falkard B, Kleinhanz RR, Karlsson J, Castellani LW, Mumick S, Wang K, Xie T, Coon M, Zhang C, Estrada-Smith D, Farber CR, Wang SS, van Nas A, Ghazalpour A, Zhang B, Macneil DJ, Lamb JR, Dipple KM, Reitman ML, Mehrabian M, Lum PY, Schadt EE, Lusis AJ, Drake TA (2009) Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet 41:415-423
36. Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397-408 (Pubitemid 43073341)
37. Zucker LM (1972) Fat mobilization in vitro and in vivo in the genetically obese Zucker rat "fatty". J Lipid Res 13:234-243
38. Zucker L, Zucker TF (1961) Fatty, a new mutation in the rat. J Heredity 52:275-278
39. Zucker TF, Zucker LM (1963) Fat accretion and growth in the rat. J Nutr 80:6-19